A Phase II Study of Dacomitinib in Progressive Brain Metastases

NCT02047747 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped slow enrollment

Conditions

Brain Cancer

Interventions

DRUG: Dacomitinib

Sponsor

David Piccioni, M.D., Ph.D

Collaborators

[object Object]